Octreotide
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Octreotide and local guidelines before prescribing.
Mechanism
Somatostatin analogue.
Uses
Acromegaly, carcinoid, variceal bleeding (selected), VIPoma, high-output stoma, hypoglycaemia due to sulfonylurea overdose.
Dosing
- IV glucose (e.g. 10% glucose 150–200 mL over 15 minutes), then a glucose infusion; consider octreotide if hypos keep recurring.
Endocrine: Anatomy Physiology and Pharmacology - IV octreotide - a bolus (e.g. 500 micrograms) then an infusion (e.g. 50–200 micrograms/hour), titrated.
Endocrinology: Emergencies - Octreotide Carcinoid crisis | IV bolus (e.g. 500 micrograms) then infusion (e.g. 50–200 micrograms/hour).
Endocrinology: Emergencies - Octreotide LAR Acromegaly | Typically 20 mg IM every 4 weeks (range 10–30 mg). Gallstones, GI upset, hyperglycaemia.
Endocrinology: Pituitary Disease
4 more dose entries from the chapters
- Drugs: Octreotide LAR (e.g. 30 mg IM every 4 weeks), lanreotide (120 mg deep SC every 4 weeks), or short-acting SC octreotide.
Endocrinology: NETS and Hypoglycaemia - Octreotide / lanreotide NETs | Octreotide LAR 30 mg IM, or lanreotide 120 mg deep SC, 4-weekly. Symptom and tumour control. Gallstones.
Endocrinology: NETS and Hypoglycaemia - Reduce gut secretions - octreotide 300–600 micrograms over 24 hours.
Palliative: Symptoms Management - Octreotide 300–600 micrograms/24 h SC | Reduces gut secretions in obstruction; high-output stomas.
Palliative: Symptoms Management
Side effects
Injection-site pain, diarrhoea, gallstones, hypo- or hyperglycaemia, bradycardia.
Interactions
Reduces ciclosporin levels; beta-blockers bradycardia.
Contraindications and cautions
Hypersensitivity
Monitoring
Glucose, gallbladder, IGF-1
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive
Special advice
Ultrasound for gallstones with long-term use; insulin needs may change.
More from the textbook: uses, cautions and other points
- Side effects - hypoglycaemia (can be prolonged , especially in older people, CKD and with long-acting drugs - may need admission and IV glucose for 24 hours or more; octreotide in refractory cases), weight gain .
Endocrine: Anatomy Physiology and Pharmacology - Carcinoid crisis | IV octreotide bolus and infusion; fluids; avoid catecholamines if possible
Endocrinology: Emergencies - Somatostatin analogues - octreotide LAR or lanreotide, monthly injections. They reduce GH and often shrink the tumour. Side effects: gallstones , GI upset, hyperglycaemia.
Endocrinology: Pituitary Disease - Control hormone release with somatostatin analogues (e.g. octreotide).
Cardiology: Valvular heart disease - Treatment: Treat the cause; drain; low-fat diet with medium-chain triglycerides; octreotide; thoracic duct embolisation or ligation.
Respiratory: Lung Cancer - Uses - acromegaly, TSH-secreting adenomas, neuroendocrine tumours (carcinoid syndrome), refractory sulfonylurea hypoglycaemia (octreotide).
Endocrine: Anatomy Physiology and Pharmacology - Octreotide / lanreotide | Acromegaly, NETs; gallstones.
Endocrine: Anatomy Physiology and Pharmacology - Sulfonylurea-induced hypoglycaemia: Can recur for 24–72 hours. Admit, give a continuous glucose infusion, and consider octreotide.
Endocrinology: Emergencies
Where it is discussed in the book
- Cardiology: Valvular heart disease (1 mention)
- Respiratory: Lung Cancer (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (4 mentions)
- Endocrinology: Emergencies (5 mentions)
- Endocrinology: Pituitary Disease (2 mentions)
- Endocrinology: NETS and Hypoglycaemia (10 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Gastroenterology: Bowel Disorders (1 mention)
- Gastroenterology: Pancreas and Biliary (1 mention)
- Oncology: Emergencies (4 mentions)
- Palliative: Symptoms Management (5 mentions)
- Surgery: Colorectal and anal surgery (1 mention)
- Surgery: Upper GI, hepatobiliary and bariatric surgery (2 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (5 mentions)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (1 mention)
- Integrated cardiology chapter (1 mention)
- Integrated respiratory chapter (1 mention)